Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis
- Conditions
- Spontaneous Bacterial Peritonitis
- Interventions
- Other: serum amyloid A level
- Registration Number
- NCT02759497
- Lead Sponsor
- Tanta University
- Brief Summary
One of the most common and serious complications in decompensated cirrhotic patients (DCPs) is bacterial infection.The most common infections in DCPs are cases of spontaneous bacterial peritonitis (SBP), which account for 40% 70% of cases, followed by urinary tract infections, pneumonia and cellulitis.
Serum amyloid A (SAA) and C-reactive protein (CRP) are acute-phase proteins predominantly produced and secreted by hepatocytes. Other cells including lymphocytes, monocytes, and macrophages can also produce these proteins. The induction of SAA and CRP synthesis is triggered by a number of cytokines, chiefly IL-6, which is released from a variety of cell types, but mainly from macrophages and monocytes at inflammatory sites
- Detailed Description
Increased serum CRP and SAA levels have been found in a number of disorders, including bacterial infections, malignancies tissue injuries and tissue rejection. Therefore, new studies of early diagnosis, prevention and treatment are needed to improve clinical outcomes.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
-
• Decompansated cirrhosis with ascites, defined by a combination of any of the following:
- Laboratory findings
- Endoscopic results
- Ultrasound
- Histology
- Creatinine>1.5 mg/dl
- Other infection e.grespiratory,UTI ,gastrointestinal and skin infection.
- Hepatocellular carcinoma
- Other extrahepatic malignancy e.g ; chest
- Any significant psychiatric illness or other medical comorbidity.
- Any degenerative diseases.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Serum amyloid A level in SBP serum amyloid A level serum amyloid A level Serum amyloid A level in cirrhosis serum amyloid A level Serum amyloid A level
- Primary Outcome Measures
Name Time Method Number of patients with elevated serum amyloid A 6months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sherief Abd-Elsalam
🇪🇬Cairo, Egypt